Medicare Enrolled
Dr. Brian Minnillo, M.D.
Urology Physician · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Minnillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Minnillo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Minnillo
Dr. Brian Minnillo is an urology physician in Cincinnati, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Minnillo performed 5,514 Medicare services across 1,947 unique beneficiaries.
Between the years covered by Open Payments, Dr. Minnillo received a total of $9,135 from 59 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Minnillo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 5% volume in OH
$9,135 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,514
Medicare services
Top 5% in OH for urology physician
1,947
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~345 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $26 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,400 | $0 | $1 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
509 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
497 | $87 | $249 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
234 | $7 | $94 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
176 | $8 | $32 |
| PSA test (prostate cancer screening) | 156 | $18 | $71 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
137 | $102 | $396 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 115 | $135 | $1,265 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
86 | $47 | $206 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
54 | $52 | $623 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
52 | $18 | $85 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
52 | $20 | $51 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
48 | $25 | $101 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
48 | $102 | $318 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
41 | $8 | $50 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
33 | $26 | $150 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
30 | $330 | $2,455 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
30 | $21 | $311 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $17 | $72 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $11 | $93 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
27 | $93 | $1,399 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
26 | $8 | $39 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $60 | $181 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
23 | $10 | $39 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
22 | $8 | $105 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
22 | $8 | $105 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
17 | $39 | $112 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
15 | $542 | $8,152 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $60 | $148 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
14 | $139 | $701 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
14 | $5 | $37 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
13 | $5 | $246 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
13 | $4 | $29 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
12 | $199 | $822 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
58.7% medium
40.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,135
Total received (2018-2024)
Avg $1,305/year across 7 years
Top 19% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,124 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,132
2023
$1,634
2022
$1,945
2021
$1,542
2020
$996
2019
$627
2018
$260
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$432
Sumitomo Pharma America, Inc.
$312
Dendreon Pharmaceuticals LLC
$295
Astellas Pharma US Inc
$173
Janssen Biotech, Inc.
$153
PROGENICS PHARMACEUTICALS, INC.
$140
BIOPROTECT MEDICAL, INC.
$117
UROGEN PHARMA, INC.
$116
Bayer Healthcare Pharmaceuticals Inc.
$79
Merck Sharp & Dohme LLC
$67
Novartis Pharmaceuticals Corporation
$60
ABBVIE INC.
$47
PROCEPT BioRobotics Corporation
$24
Myriad Genetic Laboratories, Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Axonics, Inc.
$20
ACCORD HEALTHCARE, INC.
$20
AstraZeneca Pharmaceuticals LP
$17
PFIZER INC.
$16
Top 3 companies account for 48.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,164
Astellas Pharma US Inc
$1,082
Dendreon Pharmaceuticals LLC
$780
Janssen Biotech, Inc.
$506
Bayer HealthCare Pharmaceuticals Inc.
$470
Janssen Scientific Affairs, LLC
$408
Sumitomo Pharma America, Inc.
$333
Myovant Sciences Inc.
$305
Bayer Healthcare Pharmaceuticals Inc.
$267
TOLMAR Pharmaceuticals, Inc.
$266
Merck Sharp & Dohme LLC
$262
PFIZER INC.
$250
UROGEN PHARMA, INC.
$207
Olympus America Inc.
$177
AstraZeneca Pharmaceuticals LP
$164
PROCEPT BioRobotics Corporation
$158
Axonics Modulation Technologies, Inc.
$155
Novartis Pharmaceuticals Corporation
$151
PROGENICS PHARMACEUTICALS, INC.
$140
Myriad Genetic Laboratories, Inc.
$130
BIOPROTECT MEDICAL, INC.
$117
Antares Pharma, Inc.
$114
Axonics, Inc.
$104
Foundation Medicine, Inc.
$96
UROVANT SCIENCES INC
$92
ABBVIE INC.
$86
Endo Pharmaceuticals Inc.
$83
Rochester Medical Corporation
$79
Progenics Pharmaceuticals, Inc.
$76
ACCORD HEALTHCARE, INC.
$62
Allergan, Inc.
$61
Coloplast Corp
$59
SUN PHARMACEUTICAL INDUSTRIES INC.
$59
Amgen Inc.
$56
AbbVie, Inc.
$52
ConvaTec Inc.
$48
Laborie Medical Technologies Corp.
$46
Merck Sharp & Dohme Corporation
$43
UroGen Pharma, Inc.
$43
Sun Pharmaceutical Industries Inc.
$40
NeoTract Inc.
$32
Ferring Pharmaceuticals Inc.
$29
Accord Healthcare, Inc.
$24
Acerus Pharmaceuticals Corporation
$23
Medtronic USA, Inc.
$22
Hollister Incorporated
$22
Intuitive Surgical, Inc.
$21
Blue Earth Diagnostics Limited
$20
Mission Pharmacal Company
$17
ABC Home Medical Supply, Inc.
$17
Metuchen Pharmaceuticals
$16
Allergan Inc.
$15
COLOPLAST CORP
$14
Teleflex LLC
$14
C. R. Bard, Inc. & Subsidiaries
$13
AbbVie Inc.
$13
Egalet US Inc
$12
Avadel Specialty Pharmaceuticals, LLC
$11
Clarus Therapeutics Inc.
$10
Top 3 companies account for 33.1% of all-time payments
Associated products mentioned in payments ›
AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AQUAMANTYS · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENTLECATH · General - Erectile Dysfunction · JATENZO · JELMYTO · KEYTRUDA · LITHOCLAST · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PAXLOVID · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolia · SPRIX · SpeediCath · Stendra · TITAN · TOVIAZ · Titan · Uribel · UroLift · UroLift System · VaPro · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
79
Per 100K population
37.6
County median income
$83,178
Nearest hospital
MERCY HEALTH-ANDERSON HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Minnillo is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with low-engagement industry engagement in the top 19% of OH peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Minnillo experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Minnillo performed 1,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Minnillo receive payments from pharmaceutical companies?
Yes. Dr. Minnillo received a total of $9,135 from 59 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Minnillo's costs compare to other urology physicians in Cincinnati?
Dr. Minnillo's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Minnillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cincinnati
Browse urology physicians in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology